Literature DB >> 22548717

Serum concentrations and tissue expression of components of insulin-like growth factor-axis in females with type 2 diabetes mellitus and obesity: the influence of very-low-calorie diet.

V Touskova1, P Trachta, P Kavalkova, J Drapalova, D Haluzikova, M Mraz, Z Lacinova, J Marek, M Haluzik.   

Abstract

We explored serum concentrations and mRNA expression of insulin-like-growth factor-1 (IGF-1) axis components in subcutaneous adipose tissue (SCAT) and peripheral monocytes (PM) of 18 healthy females, 11 obese non-diabetic females (OB) and 13 obese women with type 2 diabetes (T2DM) examined at baseline and after very-low-calorie diet (VLCD). T2DM women had decreased expression of IGF-1, IGF-1 receptor (IGF-1R), IGFBP-2 (IGF binding protein-2) and IGFBP-3 in SCAT and increased expression of IGF-1R in PM compared to control group. IGF-1R and IGFBP-3 mRNA expression in SCAT of OB was comparable to control group. In T2DM women VLCD increased serum levels and SCAT expression of IGFBP-2 and PM expression of IGFBP-3. We conclude that decreased IGF-1, IGF-1R and IGFBP-3 expression in SCAT and increased IGF-1R expression in PM of T2DM subjects might contribute to changes of fat differentiation capacity and to regulation of subclinical inflammation by PM, respectively. Increased SCAT and circulating IGFBP-2 and IGFBP-3 in PM might participate in metabolic improvements after VLCD.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22548717     DOI: 10.1016/j.mce.2012.04.005

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  8 in total

1.  Biomarkers of Alzheimer's disease among Mexican Americans.

Authors:  Sid E O'Bryant; Guanghua Xiao; Melissa Edwards; Michael Devous; Veer Bala Gupta; Ralph Martins; Fan Zhang; Robert Barber
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Serum IGF-binding protein 2 (IGFBP-2) concentrations change early after gastric bypass bariatric surgery revealing a possible marker of leptin sensitivity in obese subjects.

Authors:  Giovanni Ceccarini; Caterina Pelosini; Federica Ferrari; Silvia Magno; Jacopo Vitti; Guido Salvetti; Carlo Moretto; Antonio Marioni; Piero Buccianti; Paolo Piaggi; Margherita Maffei; Ferruccio Santini
Journal:  Endocrine       Date:  2019-04-03       Impact factor: 3.633

3.  The heparin-binding domains of IGFBP-2 mediate its inhibitory effect on preadipocyte differentiation and fat development in male mice.

Authors:  Gang Xi; Melissa A Solum; Christine Wai; Laura A Maile; Clifford J Rosen; David R Clemmons
Journal:  Endocrinology       Date:  2013-08-27       Impact factor: 4.736

4.  DNA-PK phosphorylation of IGFBP-3 is required to prevent apoptosis in retinal endothelial cells cultured in high glucose.

Authors:  Qiuhua Zhang; Jena J Steinle
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-30       Impact factor: 4.799

5.  Insulin-like growth factor-1 short-period therapy stimulates bone marrow cells in obese swiss mice.

Authors:  Genilza Pereira de Oliveira; Daniela Caldas de Andrade; Ana Lucia Rosa Nascimento; Erika Cortez; Simone Nunes de Carvalho; Ana Carolina Stumbo; Érica Garcia-Souza; Anibal Sanchez Moura; Laís Carvalho; Alessandra Alves Thole
Journal:  Cell Tissue Res       Date:  2021-05-11       Impact factor: 5.249

6.  Concurrent Aerobic and Resistance Training Has Anti-Inflammatory Effects and Increases Both Plasma and Leukocyte Levels of IGF-1 in Late Middle-Aged Type 2 Diabetic Patients.

Authors:  Giosuè Annibalini; Francesco Lucertini; Deborah Agostini; Luciana Vallorani; Annamaria Gioacchini; Elena Barbieri; Michele Guescini; Lucia Casadei; Annunziata Passalia; Marta Del Sal; Giovanni Piccoli; Mauro Andreani; Ario Federici; Vilberto Stocchi
Journal:  Oxid Med Cell Longev       Date:  2017-06-21       Impact factor: 6.543

Review 7.  The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes.

Authors:  Natalie J Haywood; Thomas A Slater; Connor J Matthews; Stephen B Wheatcroft
Journal:  Mol Metab       Date:  2018-10-24       Impact factor: 7.422

Review 8.  Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance.

Authors:  Hatim Boughanem; Elena M Yubero-Serrano; José López-Miranda; Francisco J Tinahones; Manuel Macias-Gonzalez
Journal:  Int J Mol Sci       Date:  2021-01-24       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.